Viewing Study NCT01632358


Ignite Creation Date: 2025-12-25 @ 12:02 AM
Ignite Modification Date: 2026-02-26 @ 12:46 AM
Study NCT ID: NCT01632358
Status: COMPLETED
Last Update Posted: 2013-12-02
First Post: 2012-06-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module